RxDoctor Payments Data

Aleksandar Krunic, MD

MOHS-Micrographic Surgery · Chicago, ILNPI 1891721965

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (50.5%), food and beverage and education — rather than concentrated in one kind of arrangement. 34 manufacturers reported payments, led by AbbVie at 25.9% of the total. Reporting peaked in 2022 at $2,216 and has fallen 70.6% since, to $652 in 2025.

$7,928in general payments, 2019–2025

Across 145 payments — averaging $54.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • EPI Health, LLC$2K
  • Galderma Laboratories, L.p.$1K
  • Johnson & Johnson$575
  • Regeneron Healthcare Solutions, Inc.$300
  • Fresenius Kabi USA, LLC$236
  • plus $2K from 28 others

What the payments were for

  • Consulting fees$4,00050%
  • Food & beverage$3,88049%
  • Education$481%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,928 in reported general payments places this provider in the 75th percentile of 40 mohs-micrographic surgery providers in Illinois.

See all mohs-micrographic surgery providers in Illinois

Medicare billing

Part B allowed, 2024
$412,016
Medicare patients
463
Services billed
2,551

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gentamicin Sulfate46$1,622
Cefadroxil75$561
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav26$274
Levocetirizine Dihydrochloride19$175
Gabapentin12$147
Amoxicillin21$125
Ketoconazole12$107
Azithromycin12$50
Finasteride12$37

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →